Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series

Abstract The incidence of breast cancer brain metastasis (BCBM) is increasing due in part to improved management of systemic disease and prolonged survival. Despite this growing population of patients, there exists little consensus for the treatment of HER2-positive BCBM. Lapatinib, the only brain p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer treatment communications 2016, Vol.7, p.43-46
Hauptverfasser:	Keith, Kevin C, Lee, Yueh, Ewend, Matthew G, Zagar, Timothy M, Anders, Carey K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adotrastuzumab Brain metastasis Breast cancer Emtansine Hematology, Oncology and Palliative Medicine Kadcyla T-DM1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!